Regarding "Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era".

Regarding "Hepatitis B surface antigen positivity is an independent unfavorable prognostic factor in diffuse large B-cell lymphoma in the rituximab era". Oncologist. 2021 Feb 08;: Authors: Picardi M, Giordano C, Della Pepa R, Pugliese N, Leone A, Delle Cave G, Iula R, Gentile G, Pane F PMID: 33559286 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33559286?dopt=Abstract

Source: The Oncologist - February 8, 2021 Category: Cancer & Oncology Authors: Picardi M, Giordano C, Della Pepa R, Pugliese N, Leone A, Delle Cave G, Iula R, Gentile G, Pane F Tags: Oncologist Source Type: research

More News: Cancer & Oncology | Hepatitis | Hepatitis B | Lymphoma | Rituxan